Cordlife Group Ltd

P8A

Company Profile

  • Business description

    Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Along with its subsidiaries, the company is engaged in the provision of diagnostics and cord blood banking services, which involve the processing and storage of cord blood stem cells. The group has two reportable segments as follows: the Banking segment, which derives maximum revenue, comprises the collection, processing, and banking of biological materials; and the Diagnostics segment, which comprises diagnostics testing services. Geographically, the group generates maximum revenue from Hong Kong, and the rest from the Philippines, India, Malaysia, Singapore, and other regions.

  • Contact

    1 Kim Seng Promenade
    No. 15-01, Great World City East
    Singapore237994
    SGP

    T: +65 62380808

    https://www.cordlife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

Stocks News & Analysis

stocks

Undervalued tech share oversold on AI fears

Has the market overlooked this ASX tech share?
stocks

Margins have bottomed for ASX listed consumer goods company

Impact of tariffs have been priced in.
stocks

SpaceX rally continues, expanding sky-high valuations

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,031.209.400.10%
CAC 408,400.1121.03-0.25%
DAX 4025,139.69153.870.62%
Dow JONES (US)51,712.71148.010.29%
FTSE 10010,437.8574.580.72%
HKSE23,768.52156.29-0.65%
NASDAQ26,166.60351.33-1.32%
Nikkei 22572,353.961,103.901.55%
NZX 50 Index13,446.0549.58-0.37%
S&P 5007,472.7927.79-0.37%
S&P/ASX 2008,816.1014.200.16%
SSE Composite Index4,163.1072.621.78%

Market Movers